LevyRH, ShenDD.Valproic acid. Absorption, distribution, and excretion. In: LevyRH, MattsonRH, MeldrumSS, eds. Antiepileptic drugs. 4th ed. New York, NY: Raven Press, Ltd.; 1995:605–619.
2.
De VaneCL.Clinical significance of drug binding, protein binding, and binding displacement drug interactions. Psychopharmacol Bull. 2002;36:5–21.
3.
StollAL, SeverusWE, FreemanMP, . Omega-3 fatty acids in bipolar disorder: a preliminary double blind, placebo-controlled trial. Arch Gen Psychiatry. 1999;56:407–412.
4.
MartinezJM, MarangellLB.Omega-3 fatty acids: do ‘fish oils’ have a therapeutic role in psychiatry? Current Psychiatry. 2004;3:25–52.
5.
KraguljacNV, MontoriVM, PavuluriM, . Efficacy of omega-3 fatty acids in mood disorders a systematic review and metaanalysis. Psychopharmacol Bull. 2009;42:39–54.
SemmesRLO, ShenDD.Capillary gas chromatographic assay for valproic acid and its 2-desaturated metabolite in brain and plasma. Chromatogr J.1988;432:185–197.
8.
Zuijdgeest-van LeeuwenSD, DagneliePC, RietveldT, . Incorporation and washout of orally administered n-3 fatty acid ethyl esters in different plasma lipid fractions. Br Nutr J.1999;82:481–488.
